国：ドイツ 取引所：Frankfurt セクター：医療 産業：バイオテクノロジー 株式市場―見積もりと価格
価格、時価総額、PE、EPSを含む全株式と自己資本のリスト
Frankfurt (648)
- {{item.name}}
- 全取引所
- Dusseldorf (1)
- Frankfurt (648)
- Munich (27)
- Stuttgart (39)
- XETRA (23)
バイオテクノロジー (648)
| 名前 名前 | 価格 価格 |
24h% 7d chart 24h% & 7d |
時価総額 時価総額 | 出来高 出来高 | 過去24時間底値 | 過去24時間高値 | 時価総額 | PER (株価収益率) | 1株当たり利益 |
|---|
| 名前 名前 | 価格 価格 |
24h% 7d chart 24h% & 7d |
時価総額 時価総額 | 出来高 出来高 | 過去24時間底値 | 過去24時間高値 | 時価総額 | PER (株価収益率) | 1株当たり利益 | |
|---|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} | |
| WuXi Biologics (Cayman) Inc. 1FW2.F | $2.61 2.85 USD |
+2.11
|
$10.76B 11.76B USD | $230 251.42 USD | $2.59 2.84 USD | $2.61 2.85 USD | $10.76B 11.76B USD | 28.98 | $0.09 0.1 USD | |
| Sino Biopharmaceutical Limited SMZ1.F | $0.44 0.48 USD |
+2.41
|
$8.11B 8.87B USD | $4K 4.37K USD | $0.44 0.48 USD | $0.44 0.48 USD | $8.11B 8.87B USD | 44.15 | $0.01 0.01 USD | |
| BB Biotech AG BBZA.F | $30.25 33.07 USD |
-0.82
|
$1.66B 1.81B USD | $3.36K 3.68K USD | $29.8 32.58 USD | $30.7 33.56 USD | $1.66B 1.81B USD | 12.39 | $2.44 2.67 USD | |
| CureVac N.V. 5CV.F | $2.87 3.14 USD |
-0.28
|
$646.65M 706.87M USD | $18.34K 20.05K USD | $2.86 3.13 USD | $2.96 3.24 USD | $646.65M 706.87M USD | 3.98 | $0.72 0.79 USD | |
| Valneva SE AYJ.F | $3.14 3.43 USD |
+1.16
|
$532.63M 582.23M USD | $11.01K 12.04K USD | $3.14 3.43 USD | $3.2 3.49 USD | $532.63M 582.23M USD | 0 | -$0.08 -0.08 USD | |
| CStone Pharmaceuticals PH4.F | $0.32 0.35 USD |
-4.82
|
$440.42M 481.43M USD | $8.12K 8.87K USD | $0.32 0.35 USD | $0.32 0.35 USD | $440.42M 481.43M USD | 0 | -$0.01 -0.01 USD | |
| Ocugen, Inc. 2H51.F | $0.65 0.71 USD |
+3.6
|
$196.83M 215.16M USD | $3K 3.28K USD | $0.65 0.71 USD | $0.65 0.71 USD | $196.83M 215.16M USD | 0 | -$0.18 -0.1 USD | |
| Abliva AB (publ) NTP.F | $0.04 0.04 USD |
0
|
$64.47M 70.47M USD | $4K 4.37K USD | $0.02999 0.03 USD | $0.04 0.04 USD | $64.47M 70.47M USD | 0 | -$0.01 -0.01 USD | |
| Alterity Therapeutics Limited PBN.F | $0.004499 0.0049 USD |
+12.5
|
$44.92M 49.1M USD | $150K 163.97K USD | $0.004499 0.0049 USD | $0.004499 0.0049 USD | $44.92M 49.1M USD | 0 | $0 0 USD | |
| Defence Therapeutics Inc. DTC.F | $0.52 0.57 USD |
-8.77
|
$28.46M 31.11M USD | $14.75K 16.12K USD | $0.4799 0.53 USD | $0.55 0.6 USD | $28.46M 31.11M USD | 0 | -$0.06 -0.06 USD | |
| Active Biotech AB (publ) BTPC.F | $0.005499 0.0060 USD |
-1.79
|
$9.46M 10.34M USD | $32.37K 35.38K USD | $0.005499 0.0060 USD | $0.005499 0.0060 USD | $9.46M 10.34M USD | 0 | -$0.01 -0.01 USD | |
| BioVaxys Technology Corp. 5LB.F | $0.02 0.02 USD |
0
|
$7.42M 8.11M USD | $598 653.69 USD | $0.02 0.02 USD | $0.02 0.02 USD | $7.42M 8.11M USD | 0 | -$0.01 -0.01 USD | |
| ImmuPharma plc 25I.F | $0.01 0.01 USD |
-45.45
|
$6.91M 7.55M USD | $75K 81.99K USD | $0.01 0.01 USD | $0.01 0.01 USD | $6.91M 7.55M USD | 0 | -$0.01 -0.01 USD | |
| Avecho Biotechnology Limited OEZ.F | $0.0015 0.0016 USD |
-50
|
$4.76M 5.2M USD | $45.31K 49.53K USD | $0.0015 0.0016 USD | $0.0015 0.0016 USD | $4.76M 5.2M USD | 0 | $0 0 USD | |
| Medigene AG MDG1.F | $0.1499 0.16 USD |
-1
|
$2.48M 2.71M USD | $21.08K 23.04K USD | $0.14 0.15 USD | $0.1499 0.17 USD | $2.48M 2.71M USD | 0 | -$1.21 -1.3 USD | |
| BioSenic S.A. BT1.F | $0.0011 0.0012 USD |
0
|
$979.29K 1.07M USD | $500K 546.57K USD | $0.0011 0.0012 USD | $0.0011 0.0012 USD | $979.29K 1.07M USD | 0 | -$0.04 -0.04 USD | |
| Novo Nordisk A/S NOVA.F | $54.3 59.36 USD |
-0.37
|
$242.93B 265.56B USD | $2.62K 2.87K USD | $53 57.94 USD | $55.7 60.89 USD | $242.93B 265.56B USD | 17.92 | $3.03 3.31 USD | |
| Vertex Pharmaceuticals Incorporated VX1.F | $431.9 472.13 USD |
-0.09
|
$111.68B 122.08B USD | $7 7.65 USD | $431.9 472.13 USD | $433.5 473.87 USD | $111.68B 122.08B USD | 0 | -$1.82 -1.9 USD | |
| CSL Limited CSJA.F | $68 74.33 USD |
+3.03
|
$67.81B 74.12B USD | $6 6.56 USD | $67.5 73.79 USD | $68 74.33 USD | $67.81B 74.12B USD | 28.21 | $2.41 2.63 USD | |
| CSL Limited CSJ.F | $136.22 148.91 USD |
+0.03
|
$65.96B 72.1B USD | $3 3.28 USD | $136.22 148.91 USD | $136.62 149.34 USD | $65.96B 72.1B USD | 28.32 | $4.81 5.26 USD | |
| Seagen Inc. SGT.F | $208.6 228.03 USD |
0
|
$39.36B 43.02B USD | $0 0 USD | $0 0 USD | $0 0 USD | $39.36B 43.02B USD | 0 | $0 0 USD | |
| argenx SE 1AEA.F | $525 573.9 USD |
+1.94
|
$32.84B 35.9B USD | $12 13.12 USD | $525 573.9 USD | $525 573.9 USD | $32.84B 35.9B USD | 46.54 | $11.28 12.33 USD | |
| argenx SE 1AE.F | $528.4 577.61 USD |
+0.84
|
$32.49B 35.51B USD | $5 5.47 USD | $528.4 577.61 USD | $528.4 577.61 USD | $32.49B 35.51B USD | 46.88 | $11.27 12.32 USD | |
| Alnylam Pharmaceuticals, Inc. DUL.F | $212.8 232.62 USD |
+0.9
|
$27.97B 30.58B USD | $30 32.79 USD | $212.8 232.62 USD | $212.8 232.62 USD | $27.97B 30.58B USD | 0 | -$1.92 -2.09 USD | |
| UCB SA UNC0.F | $71.5 78.16 USD |
0
|
$27.89B 30.49B USD | $50 54.66 USD | $71.5 78.16 USD | $71.5 78.16 USD | $27.89B 30.49B USD | 26.09 | $2.74 3 USD | |
| UCB SA UNC.F | $145.95 159.54 USD |
-0.17
|
$27.84B 30.43B USD | $15 16.4 USD | $145.95 159.54 USD | $145.95 159.54 USD | $27.84B 30.43B USD | 26.63 | $5.48 5.99 USD | |
| BeiGene, Ltd. 49B.F | $16.65 18.2 USD |
+0.85
|
$25.88B 28.29B USD | $100 109.31 USD | $16.65 18.2 USD | $16.65 18.2 USD | $25.88B 28.29B USD | 0 | -$0.41 -0.4 USD | |
| BeiGene, Ltd. 49BA.F | $218 238.3 USD |
-1.8
|
$25.2B 27.55B USD | $20 21.86 USD | $218 238.3 USD | $222 242.68 USD | $25.2B 27.55B USD | 0 | -$5.39 -5.8 USD | |
| BioNTech SE 22UA.F | $87.65 95.81 USD |
-13.39
|
$22.16B 24.22B USD | $3.27K 3.57K USD | $82.75 90.46 USD | $105.4 115.22 USD | $22.16B 24.22B USD | 0 | -$2.77 -3.02 USD | |
| Royalty Pharma plc RPD.F | $27.73 30.31 USD |
+0.73
|
$16.36B 17.88B USD | $3 3.28 USD | $27.73 30.31 USD | $28.01 30.62 USD | $16.36B 17.88B USD | 16.40 | $1.69 1.85 USD | |
| United Therapeutics Corporation UTH.F | $261.1 285.42 USD |
+1.75
|
$11.96B 13.07B USD | $20 21.86 USD | $261.1 285.42 USD | $261.1 285.42 USD | $11.96B 13.07B USD | 11.99 | $21.76 23.79 USD | |
| Insmed Incorporated IM8N.F | $60 65.59 USD |
+1.69
|
$11.26B 12.31B USD | $30 32.79 USD | $60 65.59 USD | $60.5 66.13 USD | $11.26B 12.31B USD | 0 | -$4.92 -5.3 USD | |
| BioMarin Pharmaceutical Inc. BM8.F | $55.2 60.34 USD |
+1.77
|
$10.81B 11.82B USD | $15 16.4 USD | $55.2 60.34 USD | $55.2 60.34 USD | $10.81B 11.82B USD | 28.30 | $1.95 2.13 USD | |
| WuXi Biologics (Cayman) Inc. 1FW1.F | $5.15 5.63 USD |
0
|
$10.54B 11.52B USD | $10 10.93 USD | $5.15 5.63 USD | $5.15 5.63 USD | $10.54B 11.52B USD | 27.10 | $0.19 0.21 USD | |
| Incyte Corporation ICY.F | $51.8 56.62 USD |
+1.81
|
$10.26B 11.21B USD | $6 6.56 USD | $51.8 56.62 USD | $51.8 56.62 USD | $10.26B 11.21B USD | 398.46 | $0.13 0.14 USD | |
| Akeso, Inc. 4RY.F | $11.3 12.35 USD |
-0.88
|
$10.14B 11.09B USD | $3.94K 4.31K USD | $11 12.02 USD | $11.4 12.46 USD | $10.14B 11.09B USD | 0 | -$0.07 -0.07 USD | |
| Innovent Biologics, Inc. 6IB.F | $6.05 6.61 USD |
-0.82
|
$10.1B 11.04B USD | $6.56K 7.17K USD | $6.05 6.61 USD | $6.1 6.67 USD | $10.1B 11.04B USD | 0 | -$0.01 -0.01 USD | |
| Moderna, Inc. 0QF.F | $23.67 25.87 USD |
-0.67
|
$9.29B 10.15B USD | $423 462.4 USD | $23.67 25.87 USD | $24.44 26.72 USD | $9.29B 10.15B USD | 0 | -$8.19 -8.9 USD | |
| Exelixis, Inc. EX9.F | $32.61 35.65 USD |
+1.81
|
$9.22B 10.08B USD | $757 827.5 USD | $32.61 35.65 USD | $32.61 35.65 USD | $9.22B 10.08B USD | 21.03 | $1.55 1.69 USD | |
| Ascendis Pharma A/S A71.F | $142 155.23 USD |
+2.9
|
$8.76B 9.58B USD | $50 54.66 USD | $142 155.23 USD | $142 155.23 USD | $8.76B 9.58B USD | 0 | -$6.53 -7.1 USD | |
| ImmunoGen, Inc. IMU.F | $28.74 31.42 USD |
0
|
$8.08B 8.83B USD | $0 0 USD | $0 0 USD | $0 0 USD | $8.08B 8.83B USD | 0 | $0 0 USD | |
| Verona Pharma plc I9SA.F | $55.4 60.56 USD |
-2.81
|
$7.4B 8.09B USD | $85 92.92 USD | $55 60.12 USD | $58.4 63.84 USD | $7.4B 8.09B USD | 0 | -$1.91 -2.08 USD | |
| Roivant Sciences Ltd. 87S.F | $9.54 10.43 USD |
+2.65
|
$7.11B 7.78B USD | $600 655.88 USD | $9.54 10.43 USD | $9.6 10.49 USD | $7.11B 7.78B USD | 0 | -$0.88 -0.9 USD | |
| Bio-Techne Corporation TE1.F | $43.6 47.66 USD |
-1.8
|
$6.96B 7.61B USD | $176 192.39 USD | $43.6 47.66 USD | $44.4 48.54 USD | $6.96B 7.61B USD | 50.11 | $0.87 0.95 USD | |
| Corcept Therapeutics Incorporated HTD.F | $62.82 68.67 USD |
-1.01
|
$6.63B 7.24B USD | $10 10.93 USD | $62.72 68.56 USD | $62.82 68.67 USD | $6.63B 7.24B USD | 57.63 | $1.09 1.19 USD | |
| Halozyme Therapeutics, Inc. RV7.F | $52.3 57.17 USD |
+2.07
|
$6.6B 7.21B USD | $150 163.97 USD | $52.3 57.17 USD | $52.3 57.17 USD | $6.6B 7.21B USD | 17.26 | $3.03 3.31 USD | |
| Revolution Medicines, Inc. 42Z.F | $33.6 36.73 USD |
+3.07
|
$6.53B 7.13B USD | $50 54.66 USD | $33.6 36.73 USD | $33.6 36.73 USD | $6.53B 7.13B USD | 0 | -$3.16 -3.4 USD | |
| Sirius XM Holdings Inc. R 3HY.F | $18.75 20.5 USD |
0
|
$6.39B 6.98B USD | $190 207.7 USD | $18.75 20.5 USD | $19 20.77 USD | $6.39B 6.98B USD | 0 | -$4.35 -4.7 USD | |
| Madrigal Pharmaceuticals, Inc. YDO1.F | $285 311.54 USD |
+1.89
|
$6.36B 6.95B USD | $99 108.22 USD | $276.3 302.03 USD | $285 311.54 USD | $6.36B 6.95B USD | 0 | -$19.32 -21.1 USD | |
| BridgeBio Pharma, Inc. 2CL.F | $30.89 33.77 USD |
+0.95
|
$6.1B 6.66B USD | $80 87.45 USD | $30.89 33.77 USD | $31.59 34.53 USD | $6.1B 6.66B USD | 0 | -$2.54 -2.7 USD | |
| Jazz Pharmaceuticals plc J7Z.F | $97.16 106.21 USD |
+1.8
|
$5.95B 6.5B USD | $420 459.12 USD | $95.08 103.94 USD | $97.16 106.21 USD | $5.95B 6.5B USD | 12.71 | $7.64 8.35 USD | |
| TG Therapeutics, Inc. NKB2.F | $35.26 38.54 USD |
+2.63
|
$5.74B 6.27B USD | $53 57.94 USD | $35.26 38.54 USD | $35.26 38.54 USD | $5.74B 6.27B USD | 271.23 | $0.13 0.14 USD | |
| Legend Biotech Corporation 9LB.F | $30 32.79 USD |
+0.67
|
$5.59B 6.11B USD | $135 147.57 USD | $29.8 32.58 USD | $30.2 33.01 USD | $5.59B 6.11B USD | 0 | -$0.85 -0.9 USD | |
| Sarepta Therapeutics, Inc. AB3A.F | $54.4 59.47 USD |
+4.94
|
$5.55B 6.07B USD | $12 13.12 USD | $54.4 59.47 USD | $54.4 59.47 USD | $5.55B 6.07B USD | 26.28 | $2.07 2.26 USD | |
| Financière de Tubize SA FTD.F | $116.2 127.02 USD |
+1.4
|
$5.23B 5.71B USD | $70 76.52 USD | $116.2 127.02 USD | $116.2 127.02 USD | $5.23B 5.71B USD | 57.24 | $2.03 2.22 USD | |
| Abcam plc A8C3.F | $11.7 12.79 USD |
0
|
$4.82B 5.27B USD | $0 0 USD | $0 0 USD | $0 0 USD | $4.82B 5.27B USD | 0 | $0 0 USD | |
| Blueprint Medicines Corporation 2L9.F | $73.18 80 USD |
-1.08
|
$4.8B 5.25B USD | $30 32.79 USD | $73.18 80 USD | $75.46 82.49 USD | $4.8B 5.25B USD | 0 | -$0.95 -1.03 USD | |
| Axsome Therapeutics, Inc. 19X.F | $92.34 100.94 USD |
+1.85
|
$4.62B 5.05B USD | $13 14.21 USD | $92.22 100.81 USD | $92.34 100.94 USD | $4.62B 5.05B USD | 0 | -$5.29 -5.7 USD | |
| Krystal Biotech, Inc. 4KB.F | $144 157.41 USD |
-0.31
|
$4.3B 4.7B USD | $17 18.58 USD | $144 157.41 USD | $148.3 162.11 USD | $4.3B 4.7B USD | 54.54 | $2.64 2.89 USD | |
| Cytokinetics, Incorporated KK3A.F | $35 38.26 USD |
0
|
$4.24B 4.64B USD | $59 64.49 USD | $35 38.26 USD | $35.2 38.48 USD | $4.24B 4.64B USD | 0 | -$4.64 -5.07 USD | |
| Ionis Pharmaceuticals, Inc. ISI.F | $25.91 28.32 USD |
+2.01
|
$4.23B 4.63B USD | $37 40.45 USD | $25.91 28.32 USD | $25.96 28.38 USD | $4.23B 4.63B USD | 0 | -$2.68 -2.9 USD | |
| ALK-Abelló A/S 4AJ0.F | $19.03 20.8 USD |
-3.69
|
$4.19B 4.58B USD | $1.9K 2.08K USD | $18.71 20.45 USD | $19.64 21.47 USD | $4.19B 4.58B USD | 38.83 | $0.49 0.54 USD | |
| Vaxcyte, Inc. 5VA.F | $30.2 33.01 USD |
+4.86
|
$4.11B 4.5B USD | $200 218.63 USD | $30.2 33.01 USD | $30.2 33.01 USD | $4.11B 4.5B USD | 0 | -$3.36 -3.6 USD | |
| Alpine Immune Sciences, Inc. 34LA.F | $59 64.49 USD |
0
|
$4.1B 4.48B USD | $0 0 USD | $0 0 USD | $0 0 USD | $4.1B 4.48B USD | 0 | $0 0 USD | |
| Mirati Therapeutics, Inc. 26M.F | $53.3 58.26 USD |
0
|
$3.79B 4.14B USD | $0 0 USD | $0 0 USD | $0 0 USD | $3.79B 4.14B USD | 0 | $0 0 USD | |
| Rhythm Pharmaceuticals, Inc. 1RV.F | $54 59.03 USD |
+2.86
|
$3.62B 3.95B USD | $11 12.02 USD | $54 59.03 USD | $55.5 60.67 USD | $3.62B 3.95B USD | 0 | -$3.83 -4.1 USD | |
| 3SBio Inc. 83B.F | $1.45 1.59 USD |
-1.36
|
$3.57B 3.9B USD | $432 472.23 USD | $1.45 1.59 USD | $1.46 1.6 USD | $3.57B 3.9B USD | 14.50 | $0.1 0.11 USD | |
| CymaBay Therapeutics, Inc. C0I.F | $29.8 32.58 USD |
0
|
$3.43B 3.75B USD | $0 0 USD | $0 0 USD | $0 0 USD | $3.43B 3.75B USD | 0 | $0 0 USD | |
| Camurus AB (publ) 7CA.F | $53.75 58.76 USD |
+1.99
|
$3.21B 3.51B USD | $30 32.79 USD | $53.75 58.76 USD | $53.75 58.76 USD | $3.21B 3.51B USD | 82.69 | $0.65 0.71 USD | |
| Ultragenyx Pharmaceutical Inc. UP0.F | $33 36.07 USD |
+1.23
|
$3.16B 3.45B USD | $191 208.79 USD | $33 36.07 USD | $33 36.07 USD | $3.16B 3.45B USD | 0 | -$5.56 -6.07 USD | |
| Zai Lab Limited 1ZL.F | $28.4 31.05 USD |
-2.74
|
$3.15B 3.44B USD | $230 251.42 USD | $28.4 31.05 USD | $29.6 32.36 USD | $3.15B 3.44B USD | 0 | -$2.3 -2.5 USD | |
| Asymchem Laboratories (Tianjin) Co., Ltd. 7K90.F | $5.5 6.01 USD |
-3.51
|
$3.03B 3.31B USD | $4 4.37 USD | $5.5 6.01 USD | $5.5 6.01 USD | $3.03B 3.31B USD | 16.17 | $0.34 0.37 USD | |
| Akero Therapeutics, Inc. 0K4.F | $36.08 39.44 USD |
+4.01
|
$3B 3.28B USD | $125 136.64 USD | $36.08 39.44 USD | $36.08 39.44 USD | $3B 3.28B USD | 0 | -$3.31 -3.6 USD | |
| Scholar Rock Holding Corporation 2QK.F | $29 31.7 USD |
+2.84
|
$2.96B 3.24B USD | $1.22K 1.33K USD | $29 31.7 USD | $30.2 33.01 USD | $2.96B 3.24B USD | 0 | -$2.18 -2.3 USD | |
| Crinetics Pharmaceuticals, Inc. 6Z4.F | $29.4 32.14 USD |
+4.26
|
$2.88B 3.15B USD | $60 65.59 USD | $29.4 32.14 USD | $29.4 32.14 USD | $2.88B 3.15B USD | 0 | -$3.26 -3.5 USD | |
| Genscript Biotech Corporation G51.F | $1.24 1.35 USD |
+0.08
|
$2.77B 3.02B USD | $1K 1.09K USD | $1.24 1.35 USD | $1.24 1.35 USD | $2.77B 3.02B USD | 0 | -$0.07 -0.07 USD | |
| Merus N.V. 2GH.F | $32.6 35.64 USD |
0
|
$2.71B 2.96B USD | $300 327.94 USD | $32.6 35.64 USD | $36 39.35 USD | $2.71B 2.96B USD | 0 | -$2.96 -3.2 USD | |
| Laboratorios Farmaceuticos Rovi, S.A. 41L.F | $51.2 55.97 USD |
+1.29
|
$2.65B 2.89B USD | $29 31.7 USD | $51.2 55.97 USD | $51.2 55.97 USD | $2.65B 2.89B USD | 19.17 | $2.67 2.92 USD | |
| Xenon Pharmaceuticals Inc. XP0.F | $33.6 36.73 USD |
+2.44
|
$2.64B 2.89B USD | $11 12.02 USD | $33.6 36.73 USD | $33.6 36.73 USD | $2.64B 2.89B USD | 0 | -$2.66 -2.9 USD | |
| MorphoSys AG MOR2.F | $16.8 18.36 USD |
0
|
$2.61B 2.85B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.61B 2.85B USD | 0 | $0 0 USD | |
| Morphic Holding, Inc. 31Y.F | $50 54.66 USD |
0
|
$2.6B 2.84B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.6B 2.84B USD | 0 | $0 0 USD | |
| MorphoSys AG MOR.F | $67.8 74.11 USD |
0
|
$2.55B 2.79B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.55B 2.79B USD | 0 | $0 0 USD | |
| Catalyst Pharmaceuticals, Inc. CN2.F | $20.17 22.05 USD |
+0.4
|
$2.51B 2.74B USD | $295 322.47 USD | $20.17 22.05 USD | $20.17 22.05 USD | $2.51B 2.74B USD | 17.38 | $1.16 1.27 USD | |
| Viking Therapeutics, Inc. 1VT.F | $21.27 23.25 USD |
-3.36
|
$2.46B 2.69B USD | $105 114.78 USD | $21.27 23.25 USD | $22.11 24.17 USD | $2.46B 2.69B USD | 0 | -$1.02 -1.1 USD | |
| Veracyte, Inc. 12V.F | $28 30.61 USD |
+2.19
|
$2.26B 2.47B USD | $32 34.98 USD | $28 30.61 USD | $28 30.61 USD | $2.26B 2.47B USD | 103.70 | $0.27 0.3 USD | |
| ACADIA Pharmaceuticals Inc. DR6.F | $13.03 14.24 USD |
+2.04
|
$2.23B 2.44B USD | $2.28K 2.5K USD | $13.03 14.24 USD | $13.03 14.24 USD | $2.23B 2.44B USD | 10.85 | $1.2 1.31 USD | |
| Denali Therapeutics Inc. 4DN.F | $13.63 14.89 USD |
+4.81
|
$2.08B 2.28B USD | $50 54.66 USD | $13.63 14.89 USD | $13.63 14.89 USD | $2.08B 2.28B USD | 0 | -$2.27 -2.4 USD | |
| Ascentage Pharma Group International 36X.F | $5.75 6.29 USD |
+1.77
|
$2.04B 2.23B USD | $7K 7.65K USD | $5.75 6.29 USD | $5.75 6.29 USD | $2.04B 2.23B USD | 0 | -$0.16 -0.1 USD | |
| ImmunityBio, Inc. 26CA.F | $2.26 2.47 USD |
-3.59
|
$2.02B 2.21B USD | $1.5K 1.64K USD | $2.26 2.47 USD | $2.32 2.54 USD | $2.02B 2.21B USD | 0 | -$0.55 -0.6 USD | |
| Amicus Therapeutics, Inc. AM6.F | $6.3 6.89 USD |
+2.44
|
$2B 2.19B USD | $73 79.8 USD | $6.3 6.89 USD | $6.3 6.89 USD | $2B 2.19B USD | 0 | -$0.16 -0.1 USD | |
| Vericel Corporation ATQP.F | $36.2 39.57 USD |
+4.02
|
$1.89B 2.07B USD | $50 54.66 USD | $36.2 39.57 USD | $36.2 39.57 USD | $1.89B 2.07B USD | 201.11 | $0.18 0.2 USD | |
| Apellis Pharmaceuticals, Inc. 1JK.F | $14.81 16.19 USD |
-6.25
|
$1.86B 2.03B USD | $80 87.45 USD | $14.78 16.16 USD | $14.81 16.19 USD | $1.86B 2.03B USD | 0 | -$1.41 -1.5 USD | |
| Ligand Pharmaceuticals Incorporated LGDN.F | $91 99.48 USD |
0
|
$1.85B 2.02B USD | $20 21.86 USD | $91 99.48 USD | $96 104.94 USD | $1.85B 2.02B USD | 0 | -$0.19 -0.2 USD | |
| Mirum Pharmaceuticals, Inc. 08D.F | $35 38.26 USD |
+2.94
|
$1.82B 1.99B USD | $22 24.05 USD | $34.4 37.6 USD | $35 38.26 USD | $1.82B 1.99B USD | 0 | -$1.63 -1.7 USD | |
| Everest Medicines Limited 6HN.F | $5.3 5.79 USD |
+2.91
|
$1.76B 1.93B USD | $50 54.66 USD | $5.3 5.79 USD | $5.3 5.79 USD | $1.76B 1.93B USD | 0 | -$0.39 -0.4 USD | |
| Centessa Pharmaceuticals plc 260.F | $11.5 12.57 USD |
+4.55
|
$1.67B 1.83B USD | $0 0 USD | $11.5 12.57 USD | $11.8 12.9 USD | $1.67B 1.83B USD | 0 | -$1.82 -1.9 USD | |
| Arrowhead Pharmaceuticals, Inc. HDP1.F | $11.5 12.57 USD |
+1.32
|
$1.64B 1.79B USD | $50 54.66 USD | $11.5 12.57 USD | $11.69 12.78 USD | $1.64B 1.79B USD | 0 | -$4.55 -4.9 USD | |
| Bavarian Nordic A/S BV3.F | $20.56 22.47 USD |
+1.48
|
$1.61B 1.76B USD | $258 282.03 USD | $20.28 22.17 USD | $20.56 22.47 USD | $1.61B 1.76B USD | 12.16 | $1.69 1.85 USD | |
| BioCryst Pharmaceuticals, Inc. BO1.F | $7.2 7.87 USD |
+3.75
|
$1.57B 1.72B USD | $130 142.11 USD | $7.2 7.87 USD | $7.21 7.88 USD | $1.57B 1.72B USD | 0 | -$0.38 -0.4 USD | |
| Galapagos NV GXEA.F | $23.4 25.58 USD |
+5.41
|
$1.56B 1.71B USD | $4 4.37 USD | $23 25.14 USD | $23.4 25.58 USD | $1.56B 1.71B USD | 0 | -$2.73 -2.9 USD | |
|
お気に入り銘柄なし
お気に入りの株式はまだありません。ここで表示するにはお気に入りに追加してください |
||||||||||